ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் Today - Breaking & Trending Today

Israeli drug cured COVID cases in days

Israeli drug cured COVID cases in days

February 12, 2021
Researchers at Tel Aviv’s Ichilov Hospital have discovered that a new cancer drug has been successfully used to treat patients seriously ill with the coronavirus, Kan News reported Friday.
The drug EXO-CD24 is based on a biological protein normally associated with cancer research that is known to calm the body’s immune system, which in the second stage of coronavirus attacks itself and causes severe breathing problems.
The treatment developed by Professor Nadir Arber of the Integrated Cancer Prevention Center at the hospital was tested on 30 patients in moderate and serious condition suffering from the virus with a 95 percent positive result. ....

Health Ministry , Cancer Prevention Center , Tel Aviv , Ichilov Hospital , Kan News , Professor Nadir Arber , Integrated Cancer Prevention Center , Nadir Arber , ஆரோக்கியம் அமைச்சகம் , புற்றுநோய் ப்ரெவெந்ஶந் மையம் , தொலைபேசி அவிவ் , கான் செய்தி , ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் ,

Tel Aviv's Ichilov Hospital reports success with own Covid drug

Tel Aviv s Ichilov Hospital reports success with own Covid drug
The drug was developed at the hospital by Prof. Nadir Arber. Ichilov director Prof. Ronni Gamzu: Initial results are excellent.
Ichilov Hospital in Tel Aviv has published results of a study on the effect on Covid-19 of a drug called EXO-CD24, developed at the hospital. Thirty patients in moderate to severe condition received the drug, and 29 of them were released from hospital within three to five days. The condition of the thirtieth patient has not been reported.
The results certainly arouse hope for the future. It should be pointed out, however, that several companies, in Israel and elsewhere, have reported good results from drugs to treat Covid-19, among them RedHill Biopharma Ltd. (TASE: RDHL), Kamada Ltd. (TASE: KMDA), Enlivex (TASE: ENLV) , Pluristem Therapeutics Inc. (Nasdaq:PSTI; TASE: PSTI: PSTI), and Bonus BioGroup (TASE: BONS). The current trial, like other trials carried out at this stage, was ....

Redhill Biopharma , Ronni Gamzu , Kamada Ltd , Ministry Of Health , Drug Administration , Pluristem Therapeutics Inc , Redhill Biopharma Ltd , Cancer Prevention Center , Ichilov Hospital , Tel Aviv , Pluristem Therapeutics , Bonus Biogroup , Nadir Arber , Integrated Cancer Prevention Center , அமைச்சகம் ஆஃப் ஆரோக்கியம் , புற்றுநோய் ப்ரெவெந்ஶந் மையம் , தொலைபேசி அவிவ் , போனஸ் உயிர் குழு , ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் ,

Experimental cancer drug hailed as coronavirus 'cure' by Israeli hospital

Share
However, data shows the average coronavirus patient needing hospital treatment spends up to three weeks in a bed.
Scientists gave 30 patients with serious or moderate Covid infections a dose of the drug.
It is not clear how old the patients were but data shows younger patients are much less likely to die from coronavirus and recover quicker.
Twenty-nine showed significant improvement within three to five days. It is not clear whether the patients were also receiving other drugs or treatment.
What is EXO-CD24?
Professor Nadir Arber of Ichilov Medical Center in Tel Aviv s Integrated Cancer Prevention Center spent years developing EXO-CD24 for cancer treatment before trialling it on coronavirus patients ....

Tel Aviv , Arutz Sheva , Shiran Shapira , Ichilov Medical Center , Tel Aviv Integrated Cancer Prevention Center , Ichilov Integrated Cancer Prevention Center , Nadir Arber , Integrated Cancer Prevention Center , Professor Nadir Arber , Professor Arber , தொலைபேசி அவிவ் , ஷிரான் ஷாபிரா , தொலைபேசி அவிவ் ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் , ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் ,

Israeli hospital claims may have found cure for COVID-19

Israeli hospital claims may have found cure for COVID-19
Preliminary testing shows that 29 out of 30 virus patients in serious condition that were administered the drug, dubbed EXO-CD24, once a day made a full recovery within five days; similar treatment announced by Hadassah Medical Center
Ynet |
Updated: 02.04.21 , 20:58
An Israeli hospital claims may have a cure for COVID-19, according to a report by KAN News.
Researchers at Tel Aviv s Ichilov Hospital on Thursday announced it has seen positive results in preliminary trials for a cure for COVID-19.
2 צפייה בגלריה
(Photo: TPS)
Professor Nadir Arber from the Integrated Cancer Prevention Center at the hospital tested a medication he has been developing on patients in moderate and serious condition suffering from the virus with a 95% positive result. ....

Eteläuomen Läi , Israel General , Yuval Chen , Dror Mevorach , Health Ministry Helsinki Committee , Hadassah Medical Center , Research Center , Cancer Prevention Center , Tel Aviv , Ichilov Hospital , Nadir Arber , Integrated Cancer Prevention Center , Professor Nadir Arber , Health Ministry , Helsinki Committee , Professor Dror Mevorach Director , Internal Medicine , இஸ்ரேல் ஜநரல் , ஆரோக்கியம் அமைச்சகம் ஹெல்சின்கி குழு , ஹடாஸா மருத்துவ மையம் , ஆராய்ச்சி மையம் , புற்றுநோய் ப்ரெவெந்ஶந் மையம் , தொலைபேசி அவிவ் , ஒருங்கிணைந்த புற்றுநோய் ப்ரெவெந்ஶந் மையம் , ஆரோக்கியம் அமைச்சகம் , ஹெல்சின்கி குழு ,